BioProcessors Corp. Closes $18 Million Series C Round Of Funding

Published: Jun 13, 2006

Boston, MA – June 13, 2006 – HLM Venture Partners, a leading health care venture capital firm, today announced it has led an $18 million Series C equity investment in BioProcessors Corporation, the leading provider of micro-engineered solutions for biopharmaceutical process development applications for the biotechnology and pharmaceutical industries. New Science Ventures, a firm that invests in companies that leverage breakthrough science to solve major problems, also participated in the round as did existing investors Oxford Bioscience Partners and Healthcare Ventures.

Back to news